Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Biomarker-Driven Therapy for Ovarian Cancer
Recruiting1 awardPhase 2
New York, New York
This trial will test different treatments for ovarian, fallopian tube, or primary peritoneal tumors, selected based on biomarkers. Enrollment will happen in two phases, with the possibility of expanding in the second phase.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service